What China can learn from Malaysia to achieve the goal of “eliminate hepatitis C as a public health threat” by 2030 – a narrative review
Background: To discuss a range of strategic options for China to improve the accessibility of direct antiviral agents (DAAs) as the treatment for hepatitis C.Methods: We adopted a narrative review approach for comprehensive comparisons and in-depth analyses of the country context, and barriers of in...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-11-01
|
| Series: | The Lancet Regional Health. Western Pacific |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S266660652100170X |
| _version_ | 1818840130488631296 |
|---|---|
| author | Jing Sun Hanchao Cheng Muhammad Radzi Abu Hassan Huan-Keat Chan Jean-Michel Piedagnel |
| author_facet | Jing Sun Hanchao Cheng Muhammad Radzi Abu Hassan Huan-Keat Chan Jean-Michel Piedagnel |
| author_sort | Jing Sun |
| collection | DOAJ |
| description | Background: To discuss a range of strategic options for China to improve the accessibility of direct antiviral agents (DAAs) as the treatment for hepatitis C.Methods: We adopted a narrative review approach for comprehensive comparisons and in-depth analyses of the country context, and barriers of increasing the DAA treatment rate of hepatitis C in Malaysia and China, and how the two countries have been navigating the hepatitis C agenda.Findings: Malaysia adopted a series of successful strategies to scale up the diagnosis of hepatitis C and DAA treatment, which have valuable implications for China.Interpretation: The potential game-changing strategies for China to adapt from Malaysian experiences range from the stepping-up of political commitment and leadership, enhanced market competition, simplified and decentralized treatment at the strengthened primary care level, integrated healthcare services, coordinated government initiatives, to multi-organizational participation and civil society's active role in raising public awareness, and training of non-specialist physicians. Embarking on scale-up of hepatitis C treatment marks another contribution of China to improve the health of not only the Chinese citizens but also mankind, which is an important component for building healthy Chinese and global communities.Funding: No funding supported this study. |
| first_indexed | 2024-12-19T04:05:18Z |
| format | Article |
| id | doaj.art-e93aafdef84543398d107e7822dd675c |
| institution | Directory Open Access Journal |
| issn | 2666-6065 |
| language | English |
| last_indexed | 2024-12-19T04:05:18Z |
| publishDate | 2021-11-01 |
| publisher | Elsevier |
| record_format | Article |
| series | The Lancet Regional Health. Western Pacific |
| spelling | doaj.art-e93aafdef84543398d107e7822dd675c2022-12-21T20:36:33ZengElsevierThe Lancet Regional Health. Western Pacific2666-60652021-11-0116100261What China can learn from Malaysia to achieve the goal of “eliminate hepatitis C as a public health threat” by 2030 – a narrative reviewJing Sun0Hanchao Cheng1Muhammad Radzi Abu Hassan2Huan-Keat Chan3Jean-Michel Piedagnel4PhD, School of Health Policy and Management, Chinese Academy of Medical Sciences and Peking Union Medical College, 5 Dongdansantiao, Dongcheng district, Beijing, P.R.China; Corresponding to: Jing Sun, PhD, School of Health Policy and Management, Chinese Academy of Medical Sciences and Peking Union Medical College, 5 Dongdansantiao, Dongcheng district, Beijing, P.R.ChinaMPH, School of Health Policy and Management, Chinese Academy of Medical Sciences and Peking Union Medical College, 5 Dongdansantiao, Dongcheng district, Beijing, P.R.ChinaFRCP, Clinical Research Centre, Hospital Sultanah Bahiyah, KM 6 Jalan Langgar 05460 Alor Star Kedah, MalaysiaMSc, Clinical Research Centre, Hospital Sultanah Bahiyah, KM 6 Jalan Langgar 05460 Alor Star Kedah, MalaysiaESCE, South-East Asia Regional Office, Drugs for Neglected Diseases initiative, L10-7 Menara Sentral Vista150 Jln Sultan Abdul Samad, Brickfields, 50470 Kuala Lumpur, MalaysiaBackground: To discuss a range of strategic options for China to improve the accessibility of direct antiviral agents (DAAs) as the treatment for hepatitis C.Methods: We adopted a narrative review approach for comprehensive comparisons and in-depth analyses of the country context, and barriers of increasing the DAA treatment rate of hepatitis C in Malaysia and China, and how the two countries have been navigating the hepatitis C agenda.Findings: Malaysia adopted a series of successful strategies to scale up the diagnosis of hepatitis C and DAA treatment, which have valuable implications for China.Interpretation: The potential game-changing strategies for China to adapt from Malaysian experiences range from the stepping-up of political commitment and leadership, enhanced market competition, simplified and decentralized treatment at the strengthened primary care level, integrated healthcare services, coordinated government initiatives, to multi-organizational participation and civil society's active role in raising public awareness, and training of non-specialist physicians. Embarking on scale-up of hepatitis C treatment marks another contribution of China to improve the health of not only the Chinese citizens but also mankind, which is an important component for building healthy Chinese and global communities.Funding: No funding supported this study.http://www.sciencedirect.com/science/article/pii/S266660652100170X |
| spellingShingle | Jing Sun Hanchao Cheng Muhammad Radzi Abu Hassan Huan-Keat Chan Jean-Michel Piedagnel What China can learn from Malaysia to achieve the goal of “eliminate hepatitis C as a public health threat” by 2030 – a narrative review The Lancet Regional Health. Western Pacific |
| title | What China can learn from Malaysia to achieve the goal of “eliminate hepatitis C as a public health threat” by 2030 – a narrative review |
| title_full | What China can learn from Malaysia to achieve the goal of “eliminate hepatitis C as a public health threat” by 2030 – a narrative review |
| title_fullStr | What China can learn from Malaysia to achieve the goal of “eliminate hepatitis C as a public health threat” by 2030 – a narrative review |
| title_full_unstemmed | What China can learn from Malaysia to achieve the goal of “eliminate hepatitis C as a public health threat” by 2030 – a narrative review |
| title_short | What China can learn from Malaysia to achieve the goal of “eliminate hepatitis C as a public health threat” by 2030 – a narrative review |
| title_sort | what china can learn from malaysia to achieve the goal of eliminate hepatitis c as a public health threat by 2030 a narrative review |
| url | http://www.sciencedirect.com/science/article/pii/S266660652100170X |
| work_keys_str_mv | AT jingsun whatchinacanlearnfrommalaysiatoachievethegoalofeliminatehepatitiscasapublichealththreatby2030anarrativereview AT hanchaocheng whatchinacanlearnfrommalaysiatoachievethegoalofeliminatehepatitiscasapublichealththreatby2030anarrativereview AT muhammadradziabuhassan whatchinacanlearnfrommalaysiatoachievethegoalofeliminatehepatitiscasapublichealththreatby2030anarrativereview AT huankeatchan whatchinacanlearnfrommalaysiatoachievethegoalofeliminatehepatitiscasapublichealththreatby2030anarrativereview AT jeanmichelpiedagnel whatchinacanlearnfrommalaysiatoachievethegoalofeliminatehepatitiscasapublichealththreatby2030anarrativereview |